Cresset Asset Management’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Cresset Asset Management’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-285,207	Closed	-$2.91M	–	1943
2023 Q3	$2.91M	Buy	285,207 +2,004	+0.7%	+$15.3K	0.01%	437
2023 Q2	$1.33M	Buy	+283,203	New	+$1.3M	﹤0.01%	805

Cresset Asset Management's THRN Position: Q4 2023 in Review

Cresset Asset Management sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 285,207 shares — an estimated $2.91M sold.

Cresset Asset Management first reported a position in THRN in Q2 2023 and held it in 2 quarters. The position peaked at $2.91M in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Cresset Asset Management reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Cresset Asset Management sold 285,207 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $2.91M.
Cresset Asset Management first reported a position in Thorne Healthtech, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Cresset Asset Management's Thorne Healthtech, Inc. Common Stock position peaked at $2.91M in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Cresset Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.